JP2011513310A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513310A5 JP2011513310A5 JP2010548749A JP2010548749A JP2011513310A5 JP 2011513310 A5 JP2011513310 A5 JP 2011513310A5 JP 2010548749 A JP2010548749 A JP 2010548749A JP 2010548749 A JP2010548749 A JP 2010548749A JP 2011513310 A5 JP2011513310 A5 JP 2011513310A5
- Authority
- JP
- Japan
- Prior art keywords
- ggf2
- composition
- amount
- myelination
- jun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6758908P | 2008-02-29 | 2008-02-29 | |
| US61/067,589 | 2008-02-29 | ||
| PCT/US2009/001356 WO2009108390A2 (en) | 2008-02-29 | 2009-03-02 | Method for achieving desired glial growth factor 2 plasma levels |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014212193A Division JP5964920B2 (ja) | 2008-02-29 | 2014-10-17 | グリア成長因子２の所望の血漿レベルを達成するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011513310A JP2011513310A (ja) | 2011-04-28 |
| JP2011513310A5 true JP2011513310A5 (https=) | 2012-04-19 |
| JP5697455B2 JP5697455B2 (ja) | 2015-04-08 |
Family
ID=41016663
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010548749A Expired - Fee Related JP5697455B2 (ja) | 2008-02-29 | 2009-03-02 | グリア成長因子２の所望の血漿レベルを達成するための方法 |
| JP2014212193A Expired - Fee Related JP5964920B2 (ja) | 2008-02-29 | 2014-10-17 | グリア成長因子２の所望の血漿レベルを達成するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014212193A Expired - Fee Related JP5964920B2 (ja) | 2008-02-29 | 2014-10-17 | グリア成長因子２の所望の血漿レベルを達成するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US8410050B2 (https=) |
| EP (3) | EP3120863B1 (https=) |
| JP (2) | JP5697455B2 (https=) |
| CN (2) | CN104645315A (https=) |
| AU (1) | AU2009217606B2 (https=) |
| BR (1) | BRPI0908271A2 (https=) |
| CA (1) | CA2717193C (https=) |
| ES (2) | ES2613177T3 (https=) |
| PL (2) | PL3120863T3 (https=) |
| RU (3) | RU2530650C2 (https=) |
| WO (1) | WO2009108390A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3120863T3 (pl) | 2008-02-29 | 2021-02-22 | Acorda Therapeutics, Inc. | Kompozycje do osiągnięcia pożądanych poziomów glejowego czynnika wzrostu 2 w osoczu |
| CN102159236A (zh) | 2008-07-17 | 2011-08-17 | 阿索尔达治疗公司 | 用于治疗或预防心力衰竭的神经调节蛋白或其亚序列的治疗性施剂 |
| EP2328606B1 (en) | 2008-08-15 | 2016-10-05 | Acorda Therapeutics, Inc. | Compositions and methods for treatment during non-acute periods following cns neurological injury |
| WO2011047183A2 (en) | 2009-10-14 | 2011-04-21 | Acorda Therapeutics, Inc. | Use of a neuregulin to treat peripheral nerve injury |
| CN103118698A (zh) * | 2010-05-28 | 2013-05-22 | 意识-Nrg公司 | 神经调节素同种型，神经调节素多肽和其使用 |
| WO2012021818A2 (en) * | 2010-08-13 | 2012-02-16 | Georgetown University | Ggf2 and methods of use |
| AU2013237896B2 (en) * | 2012-03-30 | 2017-11-02 | Acorda Therapeutics, Inc. | Use of neuregulin to treat peripheral nerve injury |
| JP7064197B2 (ja) * | 2016-09-23 | 2022-05-10 | 国立大学法人大阪大学 | シュワン細胞分化促進剤及び末梢神経再生促進剤 |
| CN108653274B (zh) * | 2017-04-01 | 2022-09-16 | 鲁南制药集团股份有限公司 | 牛蒡子苷元在制备治疗骨髓损伤药物中的用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7135456B1 (en) | 1991-04-10 | 2006-11-14 | Acorda Therapeutics, Inc. | Glial mitogenic factors, their preparation and use |
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US7319019B1 (en) | 1991-04-10 | 2008-01-15 | Acorda Therapeutics, Inc. | Glial mitogenic factors lacking an N-terminal signal sequence |
| US7037888B1 (en) | 1992-04-03 | 2006-05-02 | Acorda Therapeutics, Inc. | Methods for treating muscle diseases and disorders |
| GB9217316D0 (en) * | 1992-08-14 | 1992-09-30 | Ludwig Inst Cancer Res | Schwann cell mitogenic factor,its preparation and use |
| US5912326A (en) | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
| AU3003701A (en) | 1999-11-19 | 2001-05-30 | Axxima Pharmaceuticals Ag | Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| US20030232761A1 (en) | 2002-03-28 | 2003-12-18 | Hinke Simon A. | Novel analogues of glucose-dependent insulinotropic polypeptide |
| WO2004110359A2 (en) * | 2003-05-16 | 2004-12-23 | Acorda Therapeutics, Inc. | Fusion proteins for the treatment of cns |
| US20080213817A1 (en) * | 2004-02-19 | 2008-09-04 | Michael Karin | Enhancement of Th2-Dependent and Inflammatory Response |
| JP2008528697A (ja) | 2005-02-02 | 2008-07-31 | ネクサスファーマ・インコーポレイテッド | 癌の病因に関連するウィルス感染症を治療するためのアミン誘導体含有組成物および方法 |
| US7776817B2 (en) | 2005-09-02 | 2010-08-17 | Morehouse School Of Medicine | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| US20080003013A1 (en) * | 2006-06-30 | 2008-01-03 | Static Control Components, Inc. | Cartridge split rail clip |
| PL3120863T3 (pl) | 2008-02-29 | 2021-02-22 | Acorda Therapeutics, Inc. | Kompozycje do osiągnięcia pożądanych poziomów glejowego czynnika wzrostu 2 w osoczu |
| CN102834498B (zh) | 2010-04-01 | 2014-04-30 | 宝洁公司 | 织物软化剂 |
| WO2012021818A2 (en) | 2010-08-13 | 2012-02-16 | Georgetown University | Ggf2 and methods of use |
-
2009
- 2009-03-02 PL PL16182139.2T patent/PL3120863T3/pl unknown
- 2009-03-02 JP JP2010548749A patent/JP5697455B2/ja not_active Expired - Fee Related
- 2009-03-02 AU AU2009217606A patent/AU2009217606B2/en not_active Ceased
- 2009-03-02 PL PL09715322T patent/PL2262527T4/pl unknown
- 2009-03-02 EP EP16182139.2A patent/EP3120863B1/en active Active
- 2009-03-02 WO PCT/US2009/001356 patent/WO2009108390A2/en not_active Ceased
- 2009-03-02 CN CN201410709391.4A patent/CN104645315A/zh active Pending
- 2009-03-02 CA CA2717193A patent/CA2717193C/en active Active
- 2009-03-02 US US12/380,760 patent/US8410050B2/en not_active Expired - Fee Related
- 2009-03-02 ES ES09715322.5T patent/ES2613177T3/es active Active
- 2009-03-02 ES ES16182139T patent/ES2811127T3/es active Active
- 2009-03-02 EP EP20173000.9A patent/EP3750551A1/en not_active Withdrawn
- 2009-03-02 CN CN200980114836.1A patent/CN102026651B/zh not_active Expired - Fee Related
- 2009-03-02 EP EP09715322.5A patent/EP2262527B1/en active Active
- 2009-03-02 RU RU2010139906/15A patent/RU2530650C2/ru active
- 2009-03-02 BR BRPI0908271A patent/BRPI0908271A2/pt not_active IP Right Cessation
-
2013
- 2013-03-29 US US13/853,386 patent/US9272015B2/en active Active
-
2014
- 2014-07-28 RU RU2014131265A patent/RU2687097C2/ru active
- 2014-10-17 JP JP2014212193A patent/JP5964920B2/ja not_active Expired - Fee Related
-
2016
- 2016-01-21 US US15/002,608 patent/US9744215B2/en not_active Expired - Fee Related
-
2017
- 2017-07-25 US US15/658,967 patent/US10675331B2/en active Active
-
2019
- 2019-04-09 RU RU2019110452A patent/RU2019110452A/ru unknown
-
2020
- 2020-05-18 US US16/876,702 patent/US20210060128A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011513310A5 (https=) | ||
| Rentzos et al. | Serum uric acid and multiple sclerosis | |
| Dicpinigaitis | Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines | |
| RU2014131265A (ru) | Способ обеспечения требуемых уровней фактора 2 роста глии в плазме | |
| EP3265082A1 (en) | Angiotensin ii receptor agonist for treating pulmonary fibrosis | |
| RU2015110240A (ru) | Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия | |
| JP7021298B2 (ja) | Ｌ－４－クロロキヌレニンの剤形及び治療的使用 | |
| BR112014027010A2 (pt) | uso de laquinimod de alta dose para tratamento de esclerose múltipla | |
| JP6145778B2 (ja) | 特発性炎症性筋疾患の予防又は治療剤 | |
| WO2011028794A2 (en) | Treatment of huntington's disease with cycloserine and an nmda receptor antagonist | |
| CN107949379A (zh) | L‑4‑氯代犬尿氨酸的治疗用途 | |
| KR20190044667A (ko) | Fxr 작용제의 신규 요법 | |
| TW201204360A (en) | Treatment of multiple sclerosis with MASITINIB | |
| Samborski et al. | Intra‐articular treatment of arthritides and activated osteoarthritis with the 5‐HT3 receptor antagonist tropisetron. A double‐blind study compared with methylprednisolone | |
| JP6328856B2 (ja) | 収縮力低下随伴性排尿筋過活動改善剤 | |
| CN110325214A (zh) | 用于预防和治疗神经元损伤的低剂量药物组合 | |
| EP3649132A1 (en) | A peripherally-restricted dual-actingkappa | |
| Akbar | Pharmacotherapy of Sjogren’s syndrome: A comparison of disease activity with Iscalimab and Ianalumab | |
| Tavakoli et al. | Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide | |
| CN102149389A (zh) | 生物素化艾屈肝素用于降低抗血栓治疗期间出血发生率的用途 | |
| Nieri et al. | Histaminic bronchospasm potentiated by adenosine: Investigation of the mechanisms | |
| Xin et al. | Zhengzhou University, Zhengzhou, China | |
| HK40022228A (en) | Dosage forms and therapeutic uses l-4- chlorokynurenine | |
| Althobaiti | Effects of Modulating Glutamate Homeostasis in Methamphetamine and Alcohol Co-Abuse: Potential Therapeutic Targets | |
| Skotnikov et al. | FEATURES OF TREATMENT AND PROGNOSIS OF NON-ST ELEVATION ACUTE CORONARY SYNDROME IN PATIENTS WITH IRON DEFICIENCY ANEMIA: PP. 15.426 |